Trial of 5-Fluorouracil (5FU)-Based Therapy in Combination With Fruquintinib in Patients With Locally Advanced Unresectable or Metastatic Colorectal Cancer
The Methodist Hospital Research Institute
The Methodist Hospital Research Institute
Institut Paoli-Calmettes
Martini-Klinik am UKE GmbH
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Fudan University
Institut Curie
M.D. Anderson Cancer Center
UNICANCER
University of California, San Diego
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
NYU Langone Health
Azienda Ospedaliero-Universitaria di Modena
UNICANCER
Capital Medical University
Jiangsu Cancer Institute & Hospital
Fudan University
ARCAGY/ GINECO GROUP
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Chinese PLA General Hospital
Fudan University
Dana-Farber Cancer Institute
Xi'an Jiaotong University
UNICANCER
Abramson Cancer Center at Penn Medicine
University of Florida
Gustave Roussy, Cancer Campus, Grand Paris
Federation of Breast Diseases Societies
University of Leicester
Yonsei University
Institut Cancerologie de l'Ouest
Stamford Hospital
Haining Health-Coming Biotech Co., Ltd.
West China Hospital
Chinese University of Hong Kong
Georgetown University
Vrinnevi Hospital